Exposure to acrylamide decreases noradrenergic axons in rat brain

Neurotoxicology. 2020 May:78:127-133. doi: 10.1016/j.neuro.2020.03.001. Epub 2020 Mar 5.

Abstract

Purpose: Acrylamide is known to induce disorders in the central nervous system in humans and experimental animals. The present study investigated effects of exposure to acrylamide on adult neurogenesis, noradrenergic axons and the level of norepinephrine in the brain of male rats.

Method: Four groups of 12 male Wistar rats each were exposed to acrylamide at 0, 0.2, 2 and 20 mg/kg body weight by gavage for 5 weeks. Six rats of each groups were injected with 5-bromo-2'-deoxy-uridine (BrdU) after five-week exposure to acrylamide to examine proliferative cells in the dentate gyrus using immunostaining. Density of noradrenergic and serotonergic axons in the prefrontal cortex, hippocampus and cortex behind the bregma was quantified. Remaining 6 rats were decapitated after the last exposure and brains were dissected out to measure monoamine level in the hippocampus and prefrontal cortex using high performance liquid chromatography.

Result: Exposure to acrylamide dose-dependently decreased the density of noradrenergic axons in the prefrontal cortex with a significant change at 20 mg/kg. Norepinephrine level decreased in the hippocampus at 20 mg/kg. Exposure to acrylamide at 20 mg/kg or less did not change the number of BrdU positive cells, but the result should be considered preliminary.

Conclusion: The results show that oral exposure to acrylamide induces decrease in noradrenergic axons and norepinephrine level in the brain of rats. Given the similar effects are observed in 1-bromopropane-exposed rats, there may be the common mechanism in the toxicity of soft electrophiles to the central nervous system.

Keywords: Acrylamide; Electrophile; Neurotoxicity; Norepinephrine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acrylamide / toxicity*
  • Adrenergic Neurons / drug effects*
  • Adrenergic Neurons / pathology
  • Animals
  • Axons / drug effects*
  • Axons / pathology
  • Brain / drug effects*
  • Brain / pathology
  • Dopamine beta-Hydroxylase / metabolism
  • Male
  • Neurogenesis / drug effects
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / pathology
  • Rats, Wistar

Substances

  • Acrylamide
  • Dopamine beta-Hydroxylase